Alvotech and STADA add to strategic alliance through
STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well ...
Read moreSTADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well ...
Read moreThe hospital will have an additional infrastructure expansion of 300,000 sq feet with an investment of around ...
Read morePune, Maharashtra, India Investors are constantly on the lookout for investment avenues that provide stability, growth, and convenience all ...
Read moremyHQ by ANAROCK Partners With Awfis to Add 100+ New Coworking Centers for On-Demand Day Passes ...
Read moreBollywood actress Genelia Deshmukh is set to host a #DiwaliTaashParty where she will celebrate Diwali with nutritious California Pistachios. ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.